Sotera Health (NASDAQ:SHC) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its stake in shares of Sotera Health (NASDAQ:SHC) by 25.7% during the third quarter, Holdings Channel.com reports. The fund owned 32,610 shares of the company’s stock after purchasing an additional 6,666 shares during the period. Victory Capital Management Inc.’s holdings in Sotera Health were worth $545,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. CWM LLC boosted its stake in Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after purchasing an additional 993 shares in the last quarter. GAMMA Investing LLC boosted its stake in Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after buying an additional 1,660 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in Sotera Health during the third quarter worth about $91,000. Point72 DIFC Ltd raised its position in Sotera Health by 556.6% in the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock worth $78,000 after acquiring an additional 5,544 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its holdings in Sotera Health by 728.0% in the 2nd quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock valued at $111,000 after acquiring an additional 8,248 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Insider Activity at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the sale, the director now directly owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. This trade represents a 16.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 55.12% of the stock is owned by insiders.

Sotera Health Stock Performance

Sotera Health stock opened at $13.10 on Friday. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44. The firm’s 50 day simple moving average is $15.32 and its 200-day simple moving average is $14.00. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The company has a market cap of $3.71 billion, a P/E ratio of 52.40 and a beta of 2.08.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $285.47 million for the quarter, compared to analysts’ expectations of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.18 earnings per share. As a group, equities research analysts predict that Sotera Health will post 0.61 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on SHC. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Citigroup upped their price target on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Finally, Barclays raised their price objective on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and a consensus price target of $16.50.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.